OMB
.report
Search
Drug labeling requirements; prescription drugs
Labeling Requirements for Human Prescription Drug and Biological Products
OMB: 0910-0572
IC ID: 6295
OMB.report
HHS/FDA
OMB 0910-0572
ICR 202112-0910-008
IC 6295
( )
⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0572 can be found here:
2022-02-11 - No material or nonsubstantive change to a currently approved collection
Documents and Forms
Document Name
Document Type
no available documents/forms check other ICs listed under this ICR
Information Collection (IC) Details
View Information Collection (IC)
IC Title:
Drug labeling requirements; prescription drugs
Agency IC Tracking Number:
CDER
Is this a Common Form?
No
IC Status:
Modified
Obligation to Respond:
Mandatory
CFR Citation:
21 CFR subpart B 201.50 thru 201.58
21 CFR 201
(To search for a specific CFR, visit the
Code of Federal Regulations.
)
Information Collection Instruments:
Document Type
Form No.
Form Name
Instrument File
URL
Available Electronically?
Can Be Submitted Electronically?
Electronic Capability
Federal Enterprise Architecture Business Reference Module
Line of Business:
Health
Subfunction:
Consumer Health and Safety
Privacy Act System of Records
Title:
FR Citation:
Number of Respondents:
414
Number of Respondents for Small Entity:
0
Affected Public:
Private Sector
Private Sector:
Businesses or other for-profits
Percentage of Respondents Reporting Electronically:
100 %
Approved
Program Change Due to New Statute
Program Change Due to Agency Discretion
Change Due to Adjustment in Agency Estimate
Change Due to Potential Violation of the PRA
Previously Approved
Annual Number of Responses for this IC
549
0
0
8
0
541
Annual IC Time Burden (Hours)
1,838,601
0
0
579,694
0
1,258,907
Annual IC Cost Burden (Dollars)
0
0
0
0
0
0
Documents for IC
Title
Document
Date Uploaded
No associated records found
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.